ShareValue.ai

ShareValue scores for SOM.AU: Valuation 51, Quality 57, Growth 49, Health 65.

SOM.AU
ASX

Somnomed Ltd

A$0.53(-1.87%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
51
Fair Value
Price vs Value
Quality
57
Moderate
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
65
Moderate
Financial Stability
Momentum
51
Neutral
Price Trend

Company Details

About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026